Keywords: pharmacia, earnings, up, sales, rise, putting, among
Pharmacia earnings up 20%, sales rise 5%
Article | 25 July 2001
Putting it among the top performers in its peer group, Pharmacia Corphas reported first-quarter 2001 net profits of $844 million, or $0.63 per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
